The process of the clinical trials has to pass through much regulatory compliance to hit the public market. The surging clinical trials in the US are cornering these ethics by faking the data of the clinical trial process to bring in the quick results. The regulations and ethics on are too lengthy and pharmaceutical companies are looking out for a jump start to speed up the process of bringing the drug to the public market. This is crushing the underlying reason of the medical trials. I don’t say that we have to cut down the rules and ethics of the clinical trials. They are very important to ensure the safety and efficiency of the clinical trials. Instead of lengthy regulatory process, they have to run in parallel to cut down the time length of the clinical trials. This will avoid the jump start of the pharmaceutical companies to escape the ethics and regulations of the clinical trials.
No comments:
Post a Comment